Calidi Biotherapeutics, Inc.
CLDI· NYSE
CLDICalidi Biotherapeutics, Inc.
Filed Aug 10, 2022 · 10-Q · 41 days after period end · 0001193125-22-216531
| Metric | Q2 2022 | Q2 2021 |
|---|---|---|
| Net Income | -$4.58M | -$83.30K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Calidi Biotherapeutics, Inc. · CIK 1855485 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 10, 2022 · 41 d after period end
